Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.

MLA

Montanuy, Helena, et al. “Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 26, no. 12, June 2020, pp. 3044–57. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-19-1625.

APA

Montanuy, H., Martínez-Barriocanal, Á., Antonio Casado, J., Rovirosa, L., Ramírez, M. J., Nieto, R., Carrascoso-Rubio, C., Riera, P., González, A., Lerma, E., Lasa, A., Carreras-Puigvert, J., Helleday, T., Bueren, J. A., Arango, D., Minguillón, J., & Surrallés, J. (2020). Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 26(12), 3044–3057. https://doi.org/10.1158/1078-0432.CCR-19-1625

Chicago

Montanuy, Helena, Águeda Martínez-Barriocanal, José Antonio Casado, Llorenç Rovirosa, Maria José Ramírez, Rocío Nieto, Carlos Carrascoso-Rubio, et al. 2020. “Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 26 (12): 3044–57. doi:10.1158/1078-0432.CCR-19-1625.